Cargando…

Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

Sitagliptin, a modern antidiabetic agent which is weight neutral and associated with low rate of hypoglycaemias, is being increasingly used in type 2 diabetes mellitus (DM). However, there is a paucity of data about its efficacy and safety in beta-thalassaemia major (β-TM). This retrospective case s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zonoozi, Shahrzad, Barnard, Maria, Prescott, Emma, Jones, Romilla, Shah, Farrukh T, Tzoulis, Ploutarchos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224814/ https://www.ncbi.nlm.nih.gov/pubmed/28101310 http://dx.doi.org/10.4084/MJHID.2017.004

Ejemplares similares

Screening for beta thalassaemia
por: Petrou, Mary
Publicado: (2010)

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
por: Aliberti, Ludovica, et al.
Publicado: (2022)

Myocardial infarction in patients with severe beta thalassaemia: a case series
por: Premawardhena, Anuja, et al.
Publicado: (2023)

An ICET- A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism
por: Vidal, Angela, et al.
Publicado: (2022)

Osteoporosis Syndrome in Thalassaemia Major: An Overview
por: Toumba, Meropi, et al.
Publicado: (2010)

Endocrine complications in patients with thalassaemia major
por: Meng, Zhe, et al.
Publicado: (2013)

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget, et al.
Publicado: (2014)

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget S, et al.
Publicado: (2015)

Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications
por: Baldini, M., et al.
Publicado: (2014)

Prevalence, prognostic value, pathophysiology, and management of hyponatraemia in children and adolescents with COVID-19
por: Tzoulis, Ploutarchos
Publicado: (2021)

Therapy for SIAD: what does the future hold?
por: Tzoulis, Ploutarchos
Publicado: (2023)

Dynamic Dyssynchrony and Impaired Contractile Reserve of the Left Ventricle in Beta-Thalassaemia Major: An Exercise Echocardiographic Study
por: Cheung, Yiu-fai, et al.
Publicado: (2012)

Assertiveness in the patients with thalassaemia major: A qualitative study
por: Valizadeh, Leila, et al.
Publicado: (2021)

Distribution of serum lipids and lipoproteins in patients with beta thalassaemia major; an epidemiological study in young adults from Greece
por: Chrysohoou, Christina, et al.
Publicado: (2004)

Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury
por: Asakawa, Masahiro, et al.
Publicado: (2015)

α-thalassaemia
por: Harteveld, Cornelis L, et al.
Publicado: (2010)

Beta-thalassaemia major – a public health problem in Malaysia: impacts, coping strategies and needs of parents with affected children
por: Muhammad, Nursalihah, et al.
Publicado: (2012)

Left ventricular torsional mechanics and myocardial iron load in beta-thalassaemia major: a potential role of titin degradation
por: Chen, Mei-pian, et al.
Publicado: (2014)

Red cell alloantibodies in beta-thalassaemia major patients’ blood referring to the regional blood transfusion center of Tehran, Iran
por: Ebrahimisadr, Parisa, et al.
Publicado: (2021)

A Java-based Electronic Healthcare Record Software for Beta-thalassaemia
por: Deftereos, S, et al.
Publicado: (2001)

Hb E/beta-thalassaemia: a common & clinically diverse disorder
por: Olivieri, Nancy F., et al.
Publicado: (2011)

Craniofacial shape in patients with beta thalassaemia: a geometric morphometric analysis
por: Roussos, Petros, et al.
Publicado: (2021)

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
por: Engel, Samuel S, et al.
Publicado: (2013)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
por: Ballav, Chitrabhanu, et al.
Publicado: (2013)

Circulating CD133(+)VEGFR2(+) and CD34(+)VEGFR2(+) cells and arterial function in patients with beta-thalassaemia major
por: Cheung, Yiu-fai, et al.
Publicado: (2011)

Native cardiac magnetic resonance T1 mapping and cardiac mechanics as assessed by speckle tracking echocardiography in patients with beta-thalassaemia major()
por: See, Wing-Shan, et al.
Publicado: (2021)

MRI evaluation of tissue iron burden in patients with β-thalassaemia major
por: Argyropoulou, Maria I., et al.
Publicado: (2007)

Predictors of bone disease in Egyptian prepubertal children with β-thalassaemia major
por: Tantawy, Azza A.G., et al.
Publicado: (2010)

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
por: Alpendurada, Francisco, et al.
Publicado: (2012)

Development and Validation of a Multidimensional Expectation Questionnaire for Thalassaemia Major Patients
por: Koutelekos, Ioannis G., et al.
Publicado: (2016)

Evaluation of Serum Leptin Levels and Growth in Patients with β-Thalassaemia Major
por: Al-Naama, Lamia Mustafa, et al.
Publicado: (2016)

Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Oocyte quality in women with thalassaemia major: insights from IVF cycles
por: Mensi, Laura, et al.
Publicado: (2019)

Economic burden of adult patients with β-thalassaemia major in mainland China
por: Zhen, Xuemei, et al.
Publicado: (2023)

Association of hyponatremia with bone mineral density and fractures: a narrative review
por: Tzoulis, Ploutarchos, et al.
Publicado: (2023)

The erythrocyte membrane properties of beta thalassaemia heterozygotes and their consequences for Plasmodium falciparum invasion
por: Introini, Viola, et al.
Publicado: (2022)

Burden of ocular abnormalities in patients with beta thalassaemia: a cross-sectional study
por: Baig, Rashid, et al.
Publicado: (2023)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Thalassaemia Intermedia: an Update
por: Taher, Ali T., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_em2s90dtgvkeiqkuqft4ks8bmj